The role of Cdk5 in neuroendocrine thyroid cancer

Cancer Cell. 2013 Oct 14;24(4):499-511. doi: 10.1016/j.ccr.2013.08.027.

Abstract

Medullary thyroid carcinoma (MTC) is a neuroendocrine cancer that originates from calcitonin-secreting parafollicular cells, or C cells. We found that Cdk5 and its cofactors p35 and p25 are highly expressed in human MTC and that Cdk5 activity promotes MTC proliferation. A conditional MTC mouse model was generated and corroborated the role of aberrant Cdk5 activation in MTC. C cell-specific overexpression of p25 caused rapid C cell hyperplasia leading to lethal MTC, which was arrested by repressing p25 overexpression. A comparative phosphoproteomic screen between proliferating and arrested MTC identified the retinoblastoma protein (Rb) as a crucial Cdk5 downstream target. Prevention of Rb phosphorylation at Ser807/Ser811 attenuated MTC proliferation. These findings implicate Cdk5 signaling via Rb as critical to MTC tumorigenesis and progression.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Medullary / metabolism*
  • Carcinoma, Neuroendocrine / metabolism*
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Survival
  • Cyclin-Dependent Kinase 5 / metabolism*
  • Disease Progression
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Mice
  • Mice, Transgenic
  • Phosphorylation
  • Retinoblastoma Protein / metabolism
  • Signal Transduction
  • Thyroid Neoplasms / metabolism*
  • Time Factors
  • Transgenes

Substances

  • Retinoblastoma Protein
  • Cyclin-Dependent Kinase 5
  • CDK5 protein, human

Supplementary concepts

  • Thyroid cancer, medullary